Personalized Real-Time DBS and PD Mechanisms
Part of paid clinical trials in Cleveland, Ohio.
- Sponsor
- David Escobar
- Study ID
- NCT06013956
- Phase
- PHASE4
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Neurostimulation — DEVICEElectrical stimulation delivered via deep brain stimulation electrodes based on measurements of brain activity.
- Carbidopa 25/Levodopa 100Mg Tab — DRUGAnti-parkinsonian medication.
Study Details
A prospective cohort of patients scheduled to undergo deep brain stimulation (DBS) implantation surgery for the treatment of Parkinson's disease as per standard of care will be invited to participate in this study. This mechanistic study is aimed at better understanding the role of basal ganglia beta band (11-35 Hz) oscillations and resonance in the manifestation of Parkinson's disease (PD) motor signs using closed-loop electrical neurostimulation, levodopa medication, and computational modeling. The ultimate goal of this study is to inform the development of closed-loop neuromodulation technology that can be programmed and adjusted in real time based on patient-specific neural activity.
Key Dates
- Start date
- Aug 29, 2023
- Status verified
- May 2026
- Primary completion
- Jun 30, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 25 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: eiDBS suppressionClosed-loop evoked interference DBS that suppresses beta oscillations.
- No Intervention: Off DBSOff-stimulation and off-medication
- Experimental: eiDBS amplificationClosed-loop evoked interference DBS that amplifies beta oscillations.
- Experimental: Levodopa medicationOn-medication, off-stimulation
Primary Outcome Measure
Effect of eiDBS suppression vs. off-stimulation on finger tapping speed [ Time Frame: Data will be collected in assessment blocks multiple times throughout enrollment. Assessments will be performed for up to nine days, starting the day after the DBS surgery. Assessments may also be performed in one visit 3-12 months after DBS surgery. ]
Central Contacts
- David Escobar, PhD216-390-1907
- Jeffrey Negrey, MA216-316-6896
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cleveland Clinic | Cleveland | Ohio | 44195 |
Find similar trials in Cleveland, OH
Related Studies
- Abbott DBS Post-Market Study of Outcomes for Indications Over TimeRecruiting · Abbott Medical Devices · Tucson, Arizona
- Study in Parkinson Disease of ExerciseRecruiting · Northwestern University · Birmingham, Alabama
- PPMI Clinical - Establishing a Deeply Phenotyped PD CohortRecruiting · Michael J. Fox Foundation for Parkinson's Research · Birmingham, Alabama
- A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)PHASE2 · Recruiting · AskBio Inc · Irvine, California